Notice Number: NOT-DA-08-021

RFP Available: N01DA-8-7763

Key Dates
Release Date:  October 16, 2007

Issued by
National Institute on Drug Abuse (NIDA), ( http://www.nida.nih.gov )

The National Institute on Drug Abuse is soliciting proposals from qualified organizations having the capability to acquire and synthesize labeled and unlabeled drugs of abuse and other chemical compounds including opioid and related neuropeptides.  Qualified organizations must also be able to check the stability and purity of the compounds, maintain and store the compound inventory under secure conditions, and distribute the compounds to research investigators as directed by the NIDA Project Officer.  Qualified organizations must have the proper facilities, equipment and experience to complete the above-described tasks.  As some of the compounds may be scheduled under the Controlled Substances Act, demonstration of proper DEA registration and adequate security is mandatory.  In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a DEA Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances.  It is anticipated that one cost reimbursement, completion type contract will be awarded for a period of five years with additional annual option quantities.

RFP No. N01DA-8-7763 will be available electronically on or about October 22, 2007.  You will access the RFP through the FedBizOpps (URL: http://www.fedbizopps.gov) or through the NIDA website: (URL: http://www.nida.nih.gov/RFP/RFPList.html). Please note that NIDA uses a streamlined RFP format which includes only the Work Statement, Deliverables, Reporting Requirements, Special Requirements, Mandatory Qualifications, Technical Evaluation Criteria, and other necessary Proposal Preparation Instructions. All information required for the submission of a proposal is contained in or accessible through the streamlined RFP package. Response to the RFP will be due on or about December 6, 2007.  NIDA will consider proposals submitted by any responsible offeror.  This advertisement does not commit the Government to award a contract.  See Note 26.

Inquiries

Brian H. O’Laughlin, Contracting Specialist
National Institute on Drug Abuse, NIH
Contracts Management Branch, OPRM
6101 Executive Blvd., Room 260, MSC 8402
Bethesda, Maryland  20892-8402
E-mail: bo50d@nih.gov
Telephone: (301) 443-6677
Fax:  (301) 443-7595